Profile
Po Wai Yuen is a Senior Vice President-Medicinal Chemistry at Pharmaron Beijing Co., Ltd. He previously worked as a Principal at Warner-Lambert Co. and as a Vice President-Medicinal Chemistry at Psychogenics, Inc. He received his doctorate degree from the University of Pittsburgh in 1987 and his undergraduate degree from The Chinese University of Hong Kong in 1982.
Po Wai Yuen active positions
| Companies | Position | Start |
|---|---|---|
| PHARMARON BEIJING CO., LTD. | Corporate Officer/Principal | 2010-05-31 |
Former positions of Po Wai Yuen
| Companies | Position | End |
|---|---|---|
Psychogenics, Inc.
Psychogenics, Inc. BiotechnologyHealth Technology Operates as a preclinical CRO that develops therapeutics for CNS and orphan disorders | Corporate Officer/Principal | 2009-12-31 |
Warner-Lambert Co.
Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals, consumer health care and confectionery products | Corporate Officer/Principal | - |
Training of Po Wai Yuen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Warner-Lambert Co.
Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals, consumer health care and confectionery products | Health Technology |
University of Pittsburgh
University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Chinese University of Hong Kong
The Chinese University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaron Beijing Co., Ltd.
Pharmaron Beijing Co., Ltd. Pharmaceuticals: MajorHealth Technology Provides research and development, production & laboratory services for pharmaceutical and biotech industries | Health Technology |
Psychogenics, Inc.
Psychogenics, Inc. BiotechnologyHealth Technology Operates as a preclinical CRO that develops therapeutics for CNS and orphan disorders | Health Technology |
- Stock Market
- Insiders
- Po Wai Yuen
















